Contents
Issue 129 • April 2023
In association with
In Depth
Dawn of a new indication: How to study drugs for aging
Cleanroom tech tackles environmental impact of consumables
Tapping into digital therapeutics to improve neurological outcomes
CMO Moves: Regulatory catalysts for drug manufacturing – March
Q&A: Ethics of ultra-rare disease drug development and expanded access
APAC early-stage innovators raise one-third less VC funds than US players
Thematic Take
Cloud computing in the pharmaceutical industry
Powered by
